San Bruno, CA, United States of America

Hanh Giai Ngo

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanh Giai Ngo. Retrieved from https://idiyas.com/inventor/hanh-giai-ngo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hanh Giai Ngo: Innovator in Protein Engineering

Introduction

Hanh Giai Ngo is a notable inventor based in San Bruno, CA (US). He has made significant contributions to the field of protein engineering, particularly in the development of therapeutic proteins. His work focuses on addressing critical medical conditions, including Pompe disease.

Latest Patents

Hanh Giai Ngo holds a patent for "Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof." This patent describes proteins capable of being transported across the blood-brain barrier (BBB) and includes an acid alpha-glucosidase (GAA) enzyme-Fc fusion polypeptide. The methods outlined in this patent provide innovative approaches to treating Pompe disease.

Career Highlights

Hanh Giai Ngo is currently employed at Denali Therapeutics Inc., where he continues to advance his research in protein therapeutics. His work has the potential to significantly impact the treatment of genetic disorders.

Collaborations

Hanh collaborates with talented colleagues, including Mihalis S Kariolis and Melina Lenser, who contribute to the innovative environment at Denali Therapeutics Inc.

Conclusion

Hanh Giai Ngo's contributions to protein engineering and his innovative patent for treating Pompe disease highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…